Lord, Abbett & Co
IMMU

Lord, Abbett & Co’s Immunomedics Inc IMMU Stock Holding History

Lord, Abbett & Co’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-88,966
Closed -$7.57M – 720
2020
Q3 		$7.57M Sell
88,966
-3,217,377
-97% -$163M 0.02% 515
2020
Q2 		$117M Buy
+3,306,343
New +$96.7M 0.41% 54
2019
Q1 		– Sell
-553,055
Closed -$7.89M – 819
2018
Q4 		$7.89M Sell
553,055
-564,463
-51% -$11.2M 0.03% 579
2018
Q3 		$23.3M Sell
1,117,518
-323,441
-22% -$7.66M 0.06% 439
2018
Q2 		$34.1M Buy
1,440,959
+505,631
+54% +$10.2M 0.1% 324
2018
Q1 		$13.7M Sell
935,328
-2,562
-0.3% -$41.9K 0.04% 566
2017
Q4 		$15.2M Sell
937,890
-193,394
-17% -$2.28M 0.04% 539
2017
Q3 		$15.8M Sell
1,131,284
-65,799
-5% -$656K 0.05% 528
2017
Q2 		$10.6M Buy
+1,197,083
New +$8.41M 0.03% 618

Lord, Abbett & Co's IMMU Position: Q4 2020 in Review

Lord, Abbett & Co sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 88,966 shares — an estimated $7.57M sold.

Lord, Abbett & Co first reported a position in IMMU in Q2 2017 and held it in 9 quarters. The position peaked at $117M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Lord, Abbett & Co reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 88,966 Immunomedics Inc shares in Q4 2020, an estimated $7.57M.
  • Lord, Abbett & Co first reported a position in Immunomedics Inc in Q2 2017 and held it in 9 quarters.
  • Lord, Abbett & Co's Immunomedics Inc position peaked at $117M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Lord, Abbett & Co's 13F filing for Q4 2020, filed 9 Feb 2021.